OBJECTIVES: Teach HIV-negative men who have sex with men (MSM) symptoms of acute HIV infection (AHI) and direct them to nucleic acid amplification testing (NAAT) though Public Health--Seattle & King County (PHSKC). DESIGN: Cross-sectional surveys, retrospective database analysis and chart review. METHODS: Beginning in June 2009, the ru2hot? campaign described AHI symptoms and NAAT. Two preintervention and two postintervention surveys assessed campaign visibility, symptom knowledge, and healthcare-seeking behaviour. Regression analyses evaluated secular trends in case-finding. RESULTS: 366 MSM completed surveys. In survey 4, 23% of 100 men reported seeing the campaign, and 25% knew 'ru2hot?' referred to AHI. From survey 1 to survey 4, the proportion of subjects who knew ≥2 symptoms or that AHI was a 'flu-like' illness was unchanged (61% vs 57%, p=0.6). However, in survey 4, 13 (72%) of 18 subjects who saw the campaign named fever as a symptom of AHI compared with 19 (35%) of 55 subjects who had not seen the campaign (p=0.005). From 9/2003 to 12/2010, 622 (2.2%) of 27 661 MSM tested HIV-positive, and 111 (18%) were identified by the Public Health--Seattle & King County NAAT programme. In terms of the impact of the campaign on case-finding, diagnosis of EIA-negative/NAAT-positive and OraQuick-negative/EIA-positive cases increased from six in 2004 to 20 in 2010 (p=0.01), but postcampaign numbers were unchanged. 23 (51%) of 45 cases identified before and 8 (44%) of 18 cases identified after the campaign reported symptoms at initial testing (p=0.6). CONCLUSIONS: Although a quarter of MSM surveyed saw the campaign and knowledge of fever (the symptom of emphasis) was high, case-finding was unchanged. Increasing campaign visibility could have had greater impact.
OBJECTIVES: Teach HIV-negative men who have sex with men (MSM) symptoms of acute HIV infection (AHI) and direct them to nucleic acid amplification testing (NAAT) though Public Health--Seattle & King County (PHSKC). DESIGN: Cross-sectional surveys, retrospective database analysis and chart review. METHODS: Beginning in June 2009, the ru2hot? campaign described AHI symptoms and NAAT. Two preintervention and two postintervention surveys assessed campaign visibility, symptom knowledge, and healthcare-seeking behaviour. Regression analyses evaluated secular trends in case-finding. RESULTS: 366 MSM completed surveys. In survey 4, 23% of 100 men reported seeing the campaign, and 25% knew 'ru2hot?' referred to AHI. From survey 1 to survey 4, the proportion of subjects who knew ≥2 symptoms or that AHI was a 'flu-like' illness was unchanged (61% vs 57%, p=0.6). However, in survey 4, 13 (72%) of 18 subjects who saw the campaign named fever as a symptom of AHI compared with 19 (35%) of 55 subjects who had not seen the campaign (p=0.005). From 9/2003 to 12/2010, 622 (2.2%) of 27 661 MSM tested HIV-positive, and 111 (18%) were identified by the Public Health--Seattle & King County NAAT programme. In terms of the impact of the campaign on case-finding, diagnosis of EIA-negative/NAAT-positive and OraQuick-negative/EIA-positive cases increased from six in 2004 to 20 in 2010 (p=0.01), but postcampaign numbers were unchanged. 23 (51%) of 45 cases identified before and 8 (44%) of 18 cases identified after the campaign reported symptoms at initial testing (p=0.6). CONCLUSIONS: Although a quarter of MSM surveyed saw the campaign and knowledge of fever (the symptom of emphasis) was high, case-finding was unchanged. Increasing campaign visibility could have had greater impact.
Entities:
Keywords:
Education; Gay Men; Primary Hiv Infection
Authors: R Guy; J Goller; D Leslie; R Thorpe; J Grierson; C Batrouney; M Kennedy; J Lewis; C Fairley; S Ginige; I Zablotska; M Hellard Journal: J Epidemiol Community Health Date: 2009-01-29 Impact factor: 3.710
Authors: Maria J Wawer; Ronald H Gray; Nelson K Sewankambo; David Serwadda; Xianbin Li; Oliver Laeyendecker; Noah Kiwanuka; Godfrey Kigozi; Mohammed Kiddugavu; Thomas Lutalo; Fred Nalugoda; Fred Wabwire-Mangen; Mary P Meehan; Thomas C Quinn Journal: J Infect Dis Date: 2005-03-30 Impact factor: 5.226
Authors: Mark W Pandori; John Hackett; Brian Louie; Ana Vallari; Teri Dowling; Sally Liska; Jeffrey D Klausner Journal: J Clin Microbiol Date: 2009-06-17 Impact factor: 5.948
Authors: Peter R Kerndt; Robert Dubrow; Getahun Aynalem; Kenneth H Mayer; Curt Beckwith; Robert H Remien; Hong-Ha M Truong; Apurva Uniyal; Michael Chien; Ronald A Brooks; Ofilio R Vigil; Wayne T Steward; Michael Merson; Mary Jane Rotheram-Borus; Stephen F Morin Journal: AIDS Behav Date: 2009-06-03
Authors: Christine M Khosropour; Julia C Dombrowksi; James P Hughes; Lisa E Manhart; Matthew R Golden Journal: Am J Epidemiol Date: 2016-09-08 Impact factor: 4.897
Authors: Mary C Puckett; Julie S Townsend; Cynthia A Gelb; Polly Hager; Amy Conlon; Sherri L Stewart Journal: J Cancer Educ Date: 2018-12 Impact factor: 2.037
Authors: Javier Lopez-Rios; Timothy Frasca; Marcia J Kindlon; Theresa M Exner; Andrea Norcini Pala; Milton L Wainberg; Yvette Calderon; Richard Cotroneo; Arismendi A Jiménez; Robert H Remien Journal: AIDS Behav Date: 2019-10
Authors: Joanne D Stekler; Kenneth Tapia; Janine Maenza; Claire E Stevens; George A Ure; Joshua D O'Neal; Aric Lane; James I Mullins; Robert W Coombs; Sarah Holte; Ann C Collier Journal: AIDS Res Hum Retroviruses Date: 2018-06-13 Impact factor: 2.205
Authors: Joanne D Stekler; George Ure; Joshua D O'Neal; Aric Lane; Fred Swanson; Janine Maenza; Claire Stevens; Robert W Coombs; Joan Dragavon; Paul D Swenson; Matthew R Golden Journal: J Clin Virol Date: 2016-01-02 Impact factor: 3.168
Authors: Joanne D Stekler; Joshua D O'Neal; Aric Lane; Fred Swanson; Janine Maenza; Claire E Stevens; Robert W Coombs; Joan A Dragavon; Paul D Swenson; Matthew R Golden; Bernard M Branson Journal: J Clin Virol Date: 2013-12 Impact factor: 3.168
Authors: Aaron J Siegler; Travis Sanchez; R Craig Sineath; Jeremy Grey; Erin Kahle; Patrick S Sullivan Journal: Open Forum Infect Dis Date: 2015-02-23 Impact factor: 3.835